CD4+ T cells play a critical role in the generation of primary and memory antitumor immune responses elicited by SA-4-1BBL and TAA-based vaccines in mouse tumor models.
CD4+ T cells play a critical role in the generation of primary and memory antitumor immune responses elicited by SA-4-1BBL and TAA-based vaccines in mouse tumor models.
复制标题
DOI:
10.1371/journal.pone.0073145
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Shirwan H
中科院分区:
文献类型:
--
作者:
Sharma RK;Yolcu ES;Srivastava AK;Shirwan H
The role of CD4+ T cells in the generation of therapeutic primary and memory immune responses in cancer diverse immunotherapy settings remains ambiguous. We herein investigated this issue using two vaccine formulations containing a novel costimulatory molecule, SA-4-1BBL, as adjuvant and HPV E7 or survivin (SVN) as tumor associated antigens (TAAs) in two mouse transplantable tumor models; the TC-1 cervical cancer expressing xenogeneic HPV E7 and 3LL lung carcinoma overexpressing autologous SVN. Single vaccination with optimized SA-4-1BBL/TAA formulations resulted in the eradication of 6-day established TC-1 and 3LL tumors in >70% of mice in both models. The in vivo depletion of CD4+ T cells one day before tumor challenge resulted in compromised vaccine efficacy in both TC-1 (25%) and 3LL (12.5%) tumor models. In marked contrast, depletion of CD4+ T cells 5 days post-tumor challenge and one day prior to vaccination did not significantly alter the therapeutic efficacy of these vaccines. However, long-term immunological memory was compromised in the 3LL, but not in TC-1 model as a significant number (85.7%) of tumor free-mice succumbed to tumor growth when rechallenged with 3LL cells 60 days after the initial tumor inoculation. Collectively, these results demonstrate the indispensable role CD4+ T cells play in the generation of therapeutic primary immune responses elicited by SA-4-1BBL/TAA-based vaccines irrespective of the nature of TAAs and establish the importance of CD4+ T cells for long-term immune memory against 3LL tumor expressing self-antigen SVN, but not TC-1 expressing xenogeneic viral antigen E7.
登录
查看更多内容
DOI:
10.1084/jem.176.2.553
发表时间:
1992-08-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Guerder S;Matzinger P
通讯作者:
Matzinger P
影响因子:
5.5
作者:
Sharma, Rajesh K.;Srivastava, Abhishek K.;Yolcu, Esma S.;MacLeod, Kathryn J.;Schabowsky, Rich-Henry;Madireddi, Shravan;Shirwan, Haval
通讯作者:
Shirwan, Haval
影响因子:
4.4
作者:
Dolfi, Douglas V.;Duttagupta, Priyanka A.;Katsikis, Peter D.
通讯作者:
Katsikis, Peter D.
影响因子:
4.4
作者:
Bullock, TNJ;Yagita, H
通讯作者:
Yagita, H
影响因子:
5.4
作者:
FELTKAMP, MCW;SMITS, HL;KAST, WM
通讯作者:
KAST, WM